<Record><identifier xmlns="http://purl.org/dc/elements/1.1/">URN:NBN:SI:doc-LZVQ2SH1</identifier><date>2022</date><creator>Groti Antonič, Kristina</creator><relation>documents/doc/L/URN_NBN_SI_doc-LZVQ2SH1_001.pdf</relation><relation>documents/doc/L/URN_NBN_SI_doc-LZVQ2SH1_001.txt</relation><format format_type="issue">5</format><format format_type="volume">73</format><format format_type="type">article</format><format format_type="extent">str. 418-425</format><identifier identifier_type="ISSN">0014-8229</identifier><identifier identifier_type="COBISSID_HOST">136274435</identifier><identifier identifier_type="URN">URN:NBN:SI:doc-LZVQ2SH1</identifier><language>slv</language><publisher publisher_location="Ljubljana">Slovensko farmacevtsko društvo</publisher><source>Farmacevtski vestnik</source><rights>InC</rights><subject language_type_id="slv">covid-19</subject><subject language_type_id="slv">hipogonadizem</subject><subject language_type_id="slv">SARS-CoV-2</subject><subject language_type_id="slv">testisi</subject><subject language_type_id="slv">testosteron</subject><title>Effects of SARS-CoV-2 on male reproductive health</title><title>Vpliv SARS-CoV-2 na reproduktivno zdravje pri moških</title></Record>